Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Lymphatic Diseases
>>
GSK
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Nucala
(mepolizumab) / GSK
Promacta
(eltrombopag) / Novartis
Zejula
(niraparib) / GSK, J&J
Botox
(onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
Prolia
(denosumab) / Amgen
rosomidnar liposomal
(PNT2258) / GSK